Overview

Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.

Status:
Unknown status
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
A 24 - month Study looking at the the changes in visual acuity of patients receiving PDT therapy in conjunction with intravitreal triamcinolone.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Canadian Retinal Trials Group
Collaborators:
QLT Inc.
University of British Columbia
Vancouver Hospital
Treatments:
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide